- Home
- NTRB vs DMA Comparison
NTRB vs DMA Comparison
Compare NTRB & DMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NTRB
- DMA
- Stock Information
- Founded
- NTRB 2016
- DMA 2011
- Country
- NTRB United States
- DMA United States
- Employees
- NTRB N/A
- DMA N/A
- Industry
- NTRB Industrial Specialties
- DMA Trusts Except Educational Religious and Charitable
- Sector
- NTRB Health Care
- DMA Finance
- Exchange
- NTRB Nasdaq
- DMA Nasdaq
- Market Cap
- NTRB 71.8M
- DMA 78.0M
- IPO Year
- NTRB N/A
- DMA N/A
- Fundamental
- Price
- NTRB $7.15
- DMA $8.79
- Analyst Decision
- NTRB Buy
- DMA
- Analyst Count
- NTRB 1
- DMA 0
- Target Price
- NTRB $13.00
- DMA N/A
- AVG Volume (30 Days)
- NTRB 33.0K
- DMA 34.6K
- Earning Date
- NTRB 09-09-2025
- DMA 01-01-0001
- Dividend Yield
- NTRB N/A
- DMA 2.04%
- EPS Growth
- NTRB N/A
- DMA N/A
- EPS
- NTRB N/A
- DMA N/A
- Revenue
- NTRB $2,578,059.00
- DMA N/A
- Revenue This Year
- NTRB $560.75
- DMA N/A
- Revenue Next Year
- NTRB $588.39
- DMA N/A
- P/E Ratio
- NTRB N/A
- DMA N/A
- Revenue Growth
- NTRB 42.92
- DMA N/A
- 52 Week Low
- NTRB $2.98
- DMA $4.78
- 52 Week High
- NTRB $9.42
- DMA $8.00
- Technical
- Relative Strength Index (RSI)
- NTRB 59.09
- DMA 64.23
- Support Level
- NTRB $5.85
- DMA $8.55
- Resistance Level
- NTRB $7.48
- DMA $8.83
- Average True Range (ATR)
- NTRB 0.43
- DMA 0.07
- MACD
- NTRB 0.12
- DMA 0.01
- Stochastic Oscillator
- NTRB 80.26
- DMA 86.96
About NTRB Nutriband Inc.
Nutriband Inc is engaged in the development of a portfolio of transdermal pharmaceutical products. AVERSA technology is the company's product that incorporates aversive agents to prevent the Abuse, Diversion, Misuse, and Accidental exposure of drugs with abuse potential specifically Opioids. The majority of the revenue is generated from the sale of goods that include consumer transdermal and coated products.
About DMA Destra Multi-Alternative Fund
Destra Multi-Alternative Fund is a non-diversified, closed-end management investment company that operates as an interval fund with a continuous offering of fund shares. The investment objective of the fund is to seek returns from capital appreciation and income with an emphasis on income generation.